Sei Investments CO Esperion Therapeutics, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 38,556 shares of ESPR stock, worth $92,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,556

Holding current value

$92,919

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.61 - $2.73 $62,075 - $105,257	38,556 New	38,556 $63,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $7,052 - $13,149	-7,346 Reduced 35.02%	13,633 $13,000
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $13,493 - $67,466	9,242 Added 78.74%	20,979 $33,000
Q4 2022 Feb 10, 2023	SELL	$5.09 - $8.5 $4,479 - $7,480	-880 Reduced 6.97%	11,737 $73,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $68,762 - $102,576	12,617 New	12,617 $85,000
Q1 2021 May 12, 2021	SELL	$25.12 - $36.89 $333,040 - $489,087	-13,258 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$24.2 - $35.76 $2.83 Million - $4.17 Million	-116,748 Reduced 89.8%	13,258 $345,000
Q3 2020 Nov 06, 2020	SELL	$31.18 - $52.71 $267,243 - $451,777	-8,571 Reduced 6.19%	130,006 $4.83 Million
Q2 2020 Aug 17, 2020	BUY	$30.04 - $51.31 $1.75 Million - $2.98 Million	58,125 Added 72.25%	138,577 $7.11 Million
Q2 2020 Aug 11, 2020	SELL	$30.04 - $51.31 $750,609 - $1.28 Million	-24,987 Reduced 23.7%	80,452 $4.8 Million
Q1 2020 May 14, 2020	BUY	$27.44 - $73.84 $685,643 - $1.85 Million	24,987 Added 31.06%	105,439 $3.32 Million
Q4 2019 Feb 06, 2020	BUY	$35.4 - $59.82 $2.85 Million - $4.81 Million	80,452 New	80,452 $4.8 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $762 - $1,017	-19 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$40.74 - $51.41 $3,299 - $4,164	-81 Reduced 81.0%	19 $1,000
Q2 2018 Aug 03, 2018	SELL	$36.2 - $76.4 $60,635 - $127,970	-1,675 Reduced 94.37%	100 $4,000
Q1 2018 May 11, 2018	BUY	$65.94 - $80.76 $40,553 - $49,667	615 Added 53.02%	1,775 $128,000
Q4 2017 Feb 08, 2018	BUY	$43.47 - $67.43 $6,085 - $9,440	140 Added 13.73%	1,160 $76,000
Q3 2017 Nov 06, 2017	BUY	$43.8 - $52.77 $44,676 - $53,825	1,020	1,020 $51,000

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account